The structure IC-APL and how it is helping APL patients in developing countries

Eduardo Rego, MD, PhD from University of São Paulo, Brazil outlines his presentation on his experience with networking as a way of improving the assistance and results of patients with acute leukemia in developing countries. With the support of the American Society of Hematology (ASH) the International Consortium on Acute Promyelocytic Leukemia (IC-APL) was established to reduce the gap between developed and developing countries. The structure is based on networking and includes providing medical education to the community, as well as providing fast and efficient methods of diagnostics. Recorded at the European Hematology Association (EHA) 2016 Annual Congress in Copenhagen, Denmark.

Share this video